GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Hangzhou Tigermed Consulting Co Ltd (HKSE:03347) » Definitions » 3-Year Dividend Growth Rate

Hangzhou Tigermed Consulting Co (HKSE:03347) 3-Year Dividend Growth Rate : 25.50% (As of Sep. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Hangzhou Tigermed Consulting Co 3-Year Dividend Growth Rate?

Hangzhou Tigermed Consulting Co's Dividends per Share for the three months ended in Sep. 2024 was HK$0.00.

The historical rank and industry rank for Hangzhou Tigermed Consulting Co's 3-Year Dividend Growth Rate or its related term are showing as below:

HKSE:03347' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: -20.4   Med: 30.05   Max: 60.7
Current: 25.5

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Hangzhou Tigermed Consulting Co was 60.70% per year. The lowest was -20.40% per year. And the median was 30.05% per year.

HKSE:03347's 3-Year Dividend Growth Rate is ranked better than
65.79% of 38 companies
in the Medical Diagnostics & Research industry
Industry Median: 14.7 vs HKSE:03347: 25.50

During the past 12 months, Hangzhou Tigermed Consulting Co's average Dividends Per Share Growth Rate was 3.30% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 25.50% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 31.10% per year. During the past 10 years, the average Dividends Per Share Growth Rate was 22.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Hangzhou Tigermed Consulting Co's Dividend Payout Ratio for the three months ended in Sep. 2024 was 0.00. As of today, Hangzhou Tigermed Consulting Co's Dividend Yield % is 1.85%.

Warning Sign:

Hangzhou Tigermed Consulting Co Ltd stock dividend yield is close to 1-year low.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of Hangzhou Tigermed Consulting Co's 3-Year Dividend Growth Rate

For the Diagnostics & Research subindustry, Hangzhou Tigermed Consulting Co's 3-Year Dividend Growth Rate, along with its competitors' market caps and 3-Year Dividend Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hangzhou Tigermed Consulting Co's 3-Year Dividend Growth Rate Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Hangzhou Tigermed Consulting Co's 3-Year Dividend Growth Rate distribution charts can be found below:

* The bar in red indicates where Hangzhou Tigermed Consulting Co's 3-Year Dividend Growth Rate falls into.



Hangzhou Tigermed Consulting Co 3-Year Dividend Growth Rate Calculation

This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with expontential compound based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.


Hangzhou Tigermed Consulting Co  (HKSE:03347) 3-Year Dividend Growth Rate Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Hangzhou Tigermed Consulting Co's Dividend Payout Ratio for the quarter that ended in Sep. 2024 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Sep. 2024 )/ EPS without NRI (Q: Sep. 2024 )
=0/ 0.356
=0.00

During the past 13 years, the highest Dividend Payout Ratio of Hangzhou Tigermed Consulting Co was 0.64. The lowest was 0.21. And the median was 0.31.

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

Hangzhou Tigermed Consulting Co Recent Full-Year* Dividend History

Amount Ex-date Record Date Pay Date Type Frequency Forex Rate
HKD 0.6236502024-06-072024-06-122024-07-18Cash DividendannuallyHKD:HKD 1.000000

* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.

Hangzhou Tigermed Consulting Co's Dividend Yield (%) for Today is calculated as

Dividend Yield %=Most Recent Full Year Dividend/Current Share Price
=0.62365/33.80
=1.85 %

Current Share Price is HK$33.80.
Hangzhou Tigermed Consulting Co's Dividends per Share for the trailing twelve months (TTM) ended in Today is HK$0.62365.

During the past 13 years, the highest Dividend Yield of Hangzhou Tigermed Consulting Co was 1.85%. The lowest was 0.14%. And the median was 0.39%.

Warning Sign:

Hangzhou Tigermed Consulting Co Ltd stock dividend yield is close to 1-year low.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hangzhou Tigermed Consulting Co 3-Year Dividend Growth Rate Related Terms>


Hangzhou Tigermed Consulting Co Business Description

Traded in Other Exchanges
Address
Block 8, No. 19 Jugong Road, Room 2001-2010, 20th Floor, Xixing Sub-District, Binjiang District, Hangzhou, CHN, 310053
Hangzhou Tigermed Consulting Co Ltd is a China-based Contract Research Organization. The company's segment includes Clinical trial solutions and Clinical-related and laboratory services. It generates maximum revenue from the Clinical trial solutions segment. The company's offered services include bioanalytical, medical writing, biostatistics analysis, and medical imaging. The therapeutic areas of the company include Infections, Hematology, Cardiovascular, Endocrinology, Rheumatology, Nephrology, and Central Nervous System (CNS) among others.
Executives
Yi Fang Da Ji Jin Guan Li You Xian Gong Si 2102 Investment manager
Sands Capital Management, Llc 2101 Beneficial owner
Sands Capital Management, Lp 2201 Interest of corporation controlled by you
Sands Family Trust, Llc 2201 Interest of corporation controlled by you
Sands Frank Melville Jr. 2201 Interest of corporation controlled by you
Jpmorgan Chase & Co. 2201 Interest of corporation controlled by you
F-j Sands Family I, Llc 2201 Interest of corporation controlled by you
2017 Eagle Holdings Llc 2201 Interest of corporation controlled by you
Citigroup Inc. 2201 Interest of corporation controlled by you
Ubs Group Ag 2201 Interest of corporation controlled by you
Blackrock, Inc. 2201 Interest of corporation controlled by you
Brown Brothers Harriman & Co. 2502 Approved lending agent
Ninety One Plc/ Ninety One Ltd 2102 Investment manager
Ninety One Uk Limited 2102 Investment manager
Baillie Gifford & Co 2102 Investment manager

Hangzhou Tigermed Consulting Co Headlines

No Headlines